FRI0500 Evaluation of the Role of Fractalkine Chemokine CX3CL1 and Its Receptor CX3CR1 in Inflammato...
FRI0500 Evaluation of the Role of Fractalkine Chemokine CX3CL1 and Its Receptor CX3CR1 in Inflammatory Myopathies
About this item
Full title
Author / Creator
Publisher
Kidlington: Elsevier Limited
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: Elsevier Limited
More information
Scope and Contents
Contents
Background In inflammatory myopathies (IM), including polymyositis (PM), dermatomyositis (DM) and inclusion body myositis (IBM), serum creatinine kinase (CKs) can be not always reliable to evaluate disease activity. Thus, new biomarkers are required. CX3CL1/fractalkine seems to be expressed on the infiltrated inflammatory cells in muscle of murine...
Alternative Titles
Full title
FRI0500 Evaluation of the Role of Fractalkine Chemokine CX3CL1 and Its Receptor CX3CR1 in Inflammatory Myopathies
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1777978088
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1777978088
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2014-eular.4128
